The Fifth Annual Ophthalmology Summit provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. WilmerHale Partner David Redlick was a featured speaker on the panel, “Going Public – Who, When, and Why?” at this event. Additional panelists include representatives from JP Morgan, Alimera Science, Clarus Ventures, Stephens, Inc. and Ophthotech.
View a video of the panel discussion.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
